ArticleBJC reports2025

Circulating tumor DNA monitoring detects minimal residual disease and predicts outcomes in patients with esophageal adenocarcinoma or squamous cell carcinoma after esophagectomy.

Qingjiang Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.